Randomized Trialhigh evidence
Vaporized Nicotine Products for Smoking Cessation Among People Experiencing Social Disadvantage : A Randomized Clinical Trial.
Annals of internal medicine·August 1, 2025·PMID 40658956
Why it mattersSocially disadvantaged populations face higher smoking rates and lower cessation success. This trial provides strong evidence that VNPs are substantially more effective than standard NRT in this priority group, offering a potentially impactful treatment option.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled